Affiliation: Central Institute of Mental Health
- Marker gene polymorphisms in hyperkinetic disorder--predictors of clinical response to treatment with methylphenidate?G Seeger
Department of Child and Adolescent Psychiatry, Central Institute of Mental Health Mannheim, D 68072 Mannheim, Germany
Neurosci Lett 313:45-8. 2001..Thus, our study supports the hypothesis that marker gene polymorphism may be helpful in identifying MPH non-responders...
- Gene-environment interaction in hyperkinetic conduct disorder (HD + CD) as indicated by season of birth variations in dopamine receptor (DRD4) gene polymorphismGert Seeger
Department of Child and Adolescent Psychiatry, Central Institute of Mental Health Mannheim, P O Box 122120, D 68072 Mannheim, Germany
Neurosci Lett 366:282-6. 2004..Depending on the season of birth, children carrying the DRD4*7R allele showed different relative risks for developing HD + CD...
- Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's diseaseSebastian Paus
Department of Neurology, University of Bonn, Bonn, Germany
Mov Disord 19:705-7. 2004